Given the apparent important role of CD4+ cells in the induction of an effective immune response to the tumour, we studied the expression of MHC II and B7 in melanoma metastases of patients treated with IFNα, cisplatin and DTIC, in relation to the inflammatory response, regression of the tumour and survival of the patients. The gene discussed is IFNA2; the disease is neoplasm.